Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07116889 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
A Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease), sponsored by Generate Biomedicines.
- Active
- Registry status
- Phase 1
- Development phase
- 156
- Enrollment target
- 13
- Study locations
NCT07116889: Active Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease), sponsored by Generate Biomedicines.
NCT07116889 is a Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease) that is active but no longer recruiting, run by Generate Biomedicines. The registered enrollment target is 156 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower). The trial reports 13 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07116889, a Phase 1 study of Asthma and COPD (Chronic Obstructive Pulmonary Disease), is active but no longer recruiting, sponsored by Generate Biomedicines.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 156 participants
- Enrollment target
- 13
- Study locations
Study Summary
This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
Conditions Studied
Interventions
- BIOLOGICAL GB-0895 (SC)
- DRUG Placebo (SC)
Study Locations (13)
Other
- Charite Research Organization GmbH - Berlin
- IKF Pneumologie - Frankfurt
- Fraunhofer Institut fur Toxikologie and Experimentelle Medizin (ITEM) - Hanover
- Hammersmith Medicines Research - London
- Queen Anne Street Medical Center - London
- Medicines Evaluation Unit (MEU) - Manchester
- Simbec-Orion Clinical Development - Merthyr Tydfil
Florida
- Alcanza - DeLand
- Miami Research Institute of South Florida - Miami
- Omega Research - Orlando
Minnesota
- Nucleus Network - Saint Paul
North Carolina
- Southeastern Research Center - Winston-Salem
Texas
- DM Clinical Research - Tomball
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 156 participants |
| Start Date | 2023-12-12 |
| Est. Completion | 2027-05 |
| Phase | Phase 1 |
What the registry record for NCT07116889 still lists
NCT07116889 is an interventional study that assigns participants to a tested intervention. The registered 156 participants enrollment target is mid-sized for trials with a published cap, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which GB-0895 (SC) is the first listed.
NCT07116889 lists 13 locations in 5 states (Other, Florida, Minnesota).
Frequently Asked Questions
What is clinical trial NCT07116889 about?
NCT07116889 is a clinical study titled "A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD". This study is testing the safety, tolerability, pharmacokinetics and pharmacodynamics of GB-0895.
What is the current status of trial NCT07116889?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 156 participants. The study started on 2023-12-12. Estimated completion is 2027-05.
What conditions does trial NCT07116889 study?
This clinical trial studies the following conditions: Asthma, COPD (Chronic Obstructive Pulmonary Disease).
What interventions are being tested in trial NCT07116889?
The interventions under investigation include: GB-0895 (SC) (BIOLOGICAL), Placebo (SC) (DRUG).
Who is sponsoring clinical trial NCT07116889?
This trial is sponsored by Generate Biomedicines, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07116889 being conducted?
This trial has 13 study locations across Florida, Minnesota, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07116889's enrollment target sits among peer trials
156 183rd of 374 higher than 192 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RECRUITING · Phase 1
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
RECRUITING · Phase 1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
ACTIVE NOT RECRUITING · Phase 1
-
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03082755 · 156 participants · Phase 4
Nighttime Agitation and Restless Legs Syndrome in People With Alzheimer's Disease
- NCT04047628 · 156 participants · Phase 3
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- NCT04166877 · 156 participants · Phase 4
Magnesium Infusion for Pain Management in Critically Ill Trauma Patients
- NCT04533464 · 156 participants · Phase 2
MultiStem® for Treatment of Trauma Induced Multiple Organ Failure/Systemic Inflammatory Response Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI